Category Archives: 2020

PeproMene Bio Inc. submits IND for PMB-101 (BAFF-R CAR T)

Posted on October 28, 2020 by lhg-dev

Irvine, Calif., Oct. 28, 2020 (Company release) — PeproMene Bio Inc. announced today it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to study a novel chimeric antigen receptor (CAR) T cell … Continue reading →

Posted in 2020 | Leave a comment